Analysis of modified apolipoprotein B-100 structures formed in oxidized low-density lipoprotein using LC-MS/MS. 2007

Takashi Obama, and Rina Kato, and Yutaka Masuda, and Katsuhiko Takahashi, and Toshihiro Aiuchi, and Hiroyuki Itabe
Department of Biological Chemistry, School of Pharmaceutical Sciences, Showa University, Shinagawa-ku, Tokyo, Japan.

Oxidatively modified low-density lipoprotein (oxLDL) is one of the major factors involved in the development of atherosclerosis. Because of the insolubility of apolipoprotein B-100 (apoB-100) and the heterogeneous nature of oxidative modification, modified structures of apoB-100 in oxLDL are poorly understood. We applied an on-Membrane sample preparation procedure for LC-MS/MS analysis of apoB-100 proteins in native and modified low-density lipoprotein (LDL) samples to eliminate lipid components in the LDLs followed by collection of tryptic digests of apoB-100. Compared with a commonly used in-gel digestion protocol, the sample preparation procedure using PVDF membrane greatly increased the recovery of tryptic peptides and resulted in improved sequence coverage in the final analysis, which lead to the identification of modified amino acid residues in copper-induced oxLDL. A histidine residue modified by 4-hydroxynonenal, a major lipid peroxidation product, as well as oxidized histidine and tryptophan residues were detected. LC-MS/MS in combination with the on-Membrane sample preparation procedure is a useful method to analyze highly hydrophobic proteins such as apoB-100.

UI MeSH Term Description Entries
D007737 Kynurenine A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011145 Polyvinyls POLYMERS derived from the monomer VINYL COMPOUNDS. Polyvinyl
D002725 Chloroform A commonly used laboratory solvent. It was previously used as an anesthetic, but was banned from use in the U.S. due to its suspected carcinogenicity. Trichloromethane
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine

Related Publications

Takashi Obama, and Rina Kato, and Yutaka Masuda, and Katsuhiko Takahashi, and Toshihiro Aiuchi, and Hiroyuki Itabe
October 1994, Biological chemistry Hoppe-Seyler,
Takashi Obama, and Rina Kato, and Yutaka Masuda, and Katsuhiko Takahashi, and Toshihiro Aiuchi, and Hiroyuki Itabe
November 1999, Biochemistry,
Takashi Obama, and Rina Kato, and Yutaka Masuda, and Katsuhiko Takahashi, and Toshihiro Aiuchi, and Hiroyuki Itabe
March 2017, The International journal of angiology : official publication of the International College of Angiology, Inc,
Takashi Obama, and Rina Kato, and Yutaka Masuda, and Katsuhiko Takahashi, and Toshihiro Aiuchi, and Hiroyuki Itabe
January 1999, Life sciences,
Takashi Obama, and Rina Kato, and Yutaka Masuda, and Katsuhiko Takahashi, and Toshihiro Aiuchi, and Hiroyuki Itabe
August 1995, Diabetologia,
Takashi Obama, and Rina Kato, and Yutaka Masuda, and Katsuhiko Takahashi, and Toshihiro Aiuchi, and Hiroyuki Itabe
September 2000, Biochimica et biophysica acta,
Takashi Obama, and Rina Kato, and Yutaka Masuda, and Katsuhiko Takahashi, and Toshihiro Aiuchi, and Hiroyuki Itabe
August 1993, Atherosclerosis,
Takashi Obama, and Rina Kato, and Yutaka Masuda, and Katsuhiko Takahashi, and Toshihiro Aiuchi, and Hiroyuki Itabe
July 2015, Fluids and barriers of the CNS,
Takashi Obama, and Rina Kato, and Yutaka Masuda, and Katsuhiko Takahashi, and Toshihiro Aiuchi, and Hiroyuki Itabe
June 1992, Clinica chimica acta; international journal of clinical chemistry,
Takashi Obama, and Rina Kato, and Yutaka Masuda, and Katsuhiko Takahashi, and Toshihiro Aiuchi, and Hiroyuki Itabe
July 1999, Journal of biochemistry,
Copied contents to your clipboard!